« Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders at https://www.amazon.com/dp/B078313281 – electronic Table of Contents

Artificial ovary instead of conventional hormone replacement therapy »

BioMed e-Series: 18 Volumes – electronic Table of Contents of each Volume

December 12, 2017 by 2012pharmaceutical

BioMed e-Series: 18 Volumes – electronic Table of Contents (eTOCs) of each Volume

Curator: Aviva Lev-Ari, PhD, RN

CLICK on the RED Link to review eTOCs of each Volume on LinkedIn

CLICK on the BLUE Link to review eTOCs of each Volume on Amazon.com

CLICK on the GREEN Link to review DETAILED eTOCs of each Volume

on https://pharmaceuticalintelligence.com/

Series A: e-Books on Cardiovascular Diseases

Series Content Consultant: Justin D Pearlman, MD, PhD, FACC

Volume 1,2,3,4,5,6

Volume 1: Perspectives on Nitric Oxide in Disease Mechanisms

http://www.amazon.com/dp/B00DINFFYC

https://www.linkedin.com/pulse/perspectives-nitric-oxide-disease-mechanisms-table-aviva/

Cardiovascular Diseases, Volume One: Perspectives on Nitric Oxide in Disease Mechanisms

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/perspectives-on-nitric-oxide-in-disease-mechanisms-v2/

Volume 2: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation

http://www.amazon.com/dp/B018Q5MCN8

https://www.linkedin.com/pulse/cardiovascular-original-research-cases-methodology-aviva/

Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-two-cardiovascular-original-research-cases-in-methodology-design-for-content-co-curation/

Volume 3: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics

http://www.amazon.com/dp/B018PNHJ84

https://www.linkedin.com/pulse/etiologies-cardiovascular-diseases-epigenetics-lev-ari-phd-rn/

Volume Three: Etiologies of Cardiovascular Diseases – Epigenetics, Genetics and Genomics

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-three-etiologies-of-cardiovascular-diseases-epigenetics-genetics-genomics/

Volume 4: Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases

http://www.amazon.com/dp/B019UM909A

https://www.linkedin.com/pulse/regenerative-translational-medicine-therapeutics-lev-ari-phd-rn/

Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-four-therapeutic-promise-cvd-regenerative-translational-medicine/

Volumes 5: Pharmacological Agents in Treatment of Cardiovascular Diseases (Series A: Cardiovascular Diseases Book 5)

https://www.amazon.com/dp/B07MGSFDWR

https://www.linkedin.com/post/edit/pharmacological-agents-treatment-cardiovascular-book-aviva

Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-five-pharmaco-therapies-for-cvd/

Volume 6: Interventional Cardiology for Disease Diagnosis and Cardiac Surgery for Condition Treatment (Series A: Cardiovascular Diseases Book 6)

https://www.amazon.com/dp/B07MKHDBHF

https://www.linkedin.com/pulse/interventional-cardiology-disease-diagnosis-cardiac-lev-ari-phd-rn/

Volume Six: Interventional Cardiology for Disease Diagnosis and and Cardiac Surgery for Condition Treatment

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-six-interventional-cardiology-and-cardiac-surgery/

Series B: Frontiers in Genomics Research

Series Content Consultant: Prof. Marcus Feldman, Stanford University

Volume 1: Genomics Orientations for Personalized Medicine

http://www.amazon.com/dp/B018DHBUO6

https://www.linkedin.com/pulse/genomics-orientations-personalized-medicine-table-lev-ari-phd-rn/?published=t

Volume One: Genomics Orientations for Personalized Medicine

https://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-one-genomics-orientations-for-personalized-medicine/

Volume 2: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology

https://www.amazon.com/dp/B08385KF87

https://www.linkedin.com/pulse/latest-genomics-methodologies-therapeutics-gene-ngs-lev-ari-phd-rn/?published=t

Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology

https://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-two-genomics-methodologies-ngs-bioinformatics-simulations-and-the-genome-ontology/

Series C: e-Books on Cancer & Oncology

Series Content Consultant: Larry H Bernstein, MD, FCAP

Volume 1: Cancer Biology and Genomics for Disease Diagnosis

http://www.amazon.com/dp/B013RVYR2K

https://www.linkedin.com/pulse/cancer-biology-genomics-disease-diagnosis-table-lev-ari-phd-rn/

Volume One: Cancer Biology and Genomics for Disease Diagnosis

https://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/cancer-biology-and-genomics-for-disease-diagnosis/

Volume 2: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery

http://www.amazon.com/dp/B071VQ6YYK

https://www.linkedin.com/pulse/cancer-therapies-metabolic-genomics-interventional-lev-ari-phd-rn/?published=t

Volume Two: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery

https://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/volume-2-immunotherapy-in-oncology/

Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases &

Genomic Endocrinology

Series Content Consultant: Larry H Bernstein, MD, FCAP

Volume 1: Metabolic Genomics & Pharmaceutics electronic Table of Contents

http://www.amazon.com/dp/B012BB0ZF0

https://www.linkedin.com/pulse/metabolic-genomics-pharmaceutics-electronic-table-lev-ari-phd-rn/

Volume One: Metabolic Genomics & Pharmaceutics

https://pharmaceuticalintelligence.com/biomed-e-books/series-d-e-books-on-biomedicine/metabolic-genomics-pharmaceutics/

Volume 2 & Volume 3:

https://www.amazon.com/dp/B075CXHY1B

Volume 2: Infectious Diseases and Therapeutics e-Table of Contents, Volume 2

https://www.linkedin.com/pulse/infectious-diseases-therapeutics-e-table-contents-2-lev-ari-phd-rn/

Series D, Volume Two & Three: The Immune System, Stress Signaling, Infectious Diseases and Therapeutic Implications & Genomic Endocrinology

https://pharmaceuticalintelligence.com/biomed-e-books/series-d-e-books-on-biomedicine/human-immune-system-in-health-and-in-disease/

Volume 3: The Immune System and Therapeutics

https://www.linkedin.com/pulse/immune-system-therapeutics-e-table-contents-aviva-lev-ari-phd-rn/?published=t

Series D, Volume Two & Three: The Immune System, Stress Signaling, Infectious Diseases and Therapeutic Implications & Genomic Endogrinology

https://pharmaceuticalintelligence.com/biomed-e-books/series-d-e-books-on-biomedicine/human-immune-system-in-health-and-in-disease/

Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases, Reproductive Genomic Endocrinology

Volume 4: Human Reproductive System, Genomic Endocrinology and Cancer Types

http://www.amazon.com/dp/B08VTFWVKM

Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases, Reproductive Genomic Endocrinology

https://www.linkedin.com/pulse/human-reproductive-system-genomic-endocrinology-types-aviva/

https://pharmaceuticalintelligence.com/biomed-e-books/series-d-e-books-on-biomedicine/series-d-volume-4-human-reproductive-system-genomic-endocrinology-and-cancer-types/

Series E: Patient-Centered Medicine

Series Content Consultant: Larry H Bernstein, MD, FCAP

Volume 1:

The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families

https://www.amazon.com/dp/B076HGB6MZ

https://www.linkedin.com/pulse/voices-patients-hospitals-ceos-health-care-providers-aviva/

Volume One: The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families: Personal Experience with Critical Care and Invasive Medical Procedures

https://pharmaceuticalintelligence.com/biomed-e-books/series-e-titles-in-the-strategic-plan-for-2014-1015/2014-the-patients-voice-personal-experience-with-invasive-medical-procedures/

Volume 2:

Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders

https://www.amazon.com/dp/B078313281

https://www.linkedin.com/pulse/medical-scientific-discoveries-21st-century-leaders-lev-ari-phd-rn/

Volume Two: Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders

https://pharmaceuticalintelligence.com/biomed-e-books/series-e-titles-in-the-strategic-plan-for-2014-1015/2014-interviews-with-scientific-leaders/

Volume 3:

Milestones in Physiology – Discoveries in Medicine, Genomics and Therapeutics Patient-centric Perspective

http://www.amazon.com/dp/B019VH97LU

https://www.linkedin.com/pulse/milestones-physiology-discoveries-medicine-genomics-aviva/

Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics

https://pharmaceuticalintelligence.com/biomed-e-books/series-e-titles-in-the-strategic-plan-for-2014-1015/2014-milestones-in-physiology-discoveries-in-medicine/

Volume 4

Medical 3D BioPrinting – The Revolution in Medicine -Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices

https://www.amazon.com/dp/B078QVDV2W

https://www.linkedin.com/pulse/medical-3d-bioprinting-revolution-medicine-from-rd-lev-ari-phd-rn/?published=t

Volume Four: Medical 3D BioPrinting – The Revolution in Medicine

https://pharmaceuticalintelligence.com/biomed-e-books/series-e-titles-in-the-strategic-plan-for-2014-1015/volume-four-medical-3d-bioprinting-the-revolution-in-medicine/

BioMed e-Series

https://pharmaceuticalintelligence.com/biomed-e-books/

BioMed e-Series

WE ARE ON AMAZON.COM with 18 Books in Medicine

ekWGNqA

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

http://www.amazon.com/dp/B071VQ6YYK

https://www.amazon.com/dp/B075CXHY1B

https://www.amazon.com/dp/B076HGB6MZ

https://www.amazon.com/dp/B078313281

https://www.amazon.com/dp/B078QVDV2W

https://www.amazon.com/dp/B07MGSFDWR

https://www.amazon.com/dp/B07MKHDBHF

https://www.amazon.com/dp/B08385KF87

http://www.amazon.com/dp/B08VTFWVKM

Posted in BioMed e-Books e-Series by LPBI Group, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management | 1 Comment

One Response

on September 8, 2021 at 9:26 AM | Reply Data Architecture for Blockchain Deployment of Digital Assets: LPBI IP Asset Classes I,II,III,V | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

This is very insightful. There is no doubt that there is the bias you refer to. 42 years ago, when I was postdocing in biochemistry/enzymology before completing my residency in pathology, I knew that there were very influential mambers of the faculty, who also had large programs, and attracted exceptional students. My mentor, it was said (although he was a great writer), could draft a project on toilet paper and call the NIH. It can’t be true, but it was a time in our history preceding a great explosion. It is bizarre for me to read now about eNOS and iNOS, and about CaMKII-á, â, ã, ä – isoenzymes. They were overlooked during the search for the genome, so intermediary metabolism took a back seat. But the work on protein conformation, and on the mechanism of action of enzymes and ligand and coenzyme was just out there, and became more important with the research on signaling pathways. The work on the mechanism of pyridine nucleotide isoenzymes preceded the work by Burton Sobel on the MB isoenzyme in heart. The Vietnam War cut into the funding, and it has actually declined linearly since.

A few years later, I was an Associate Professor at a new Medical School and I submitted a proposal that was reviewed by the Chairman of Pharmacology, who was a former Director of NSF. He thought it was good enough. I was a pathologist and it went to a Biochemistry Review Committee. It was approved, but not funded. The verdict was that I would not be able to carry out the studies needed, and they would have approached it differently. A thousand young investigators are out there now with similar letters. I was told that the Department Chairmen have to build up their faculty. It’s harder now than then. So I filed for and received 3 patents based on my work at the suggestion of my brother-in-law. When I took it to Boehringer-Mannheim, they were actually clueless.

Loading...